(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
最近の投稿
- 1
Ukraine demands army of 800,000 under peace plan - 2Vote in favor of your Favored sort of footwear
- 3Ukrainian troops showed 'greater tactical imagination' than Western trainers, British officer says, pointing to their ambush tactics
- 4Weight-loss pill approval set to accelerate food industry product overhauls
- 5Picking the Right Home Machines: A Commonsense Aide
- Behind every perfect holiday memory is a mom on the brink
- Ways to track down the Right Criminal Legal counselor
- James Webb Space telescope spots 'big red dot' in the ancient universe: A ravenous supermassive black hole named 'BiRD'
- Elite Execution Wall televisions for Film Darlings
- Dave Coulier reveals he has tongue cancer, his 2nd diagnosis in a year, after beating non-Hodgkin lymphoma
- German hauliers warn soaring energy prices may soon impact consumers
- Exhaustive Experiences into Prudent Senior Living in the UK
- CDC advisory panel delays vote on hepatitis B vaccines after unruly meeting
- Tatiana Schlossberg, a granddaughter of JFK, is dead at 35 after cancer diagnosis
